Detection of normal and chimeric nucleophosmin in human cells.
暂无分享,去创建一个
B Falini | P G Pelicci | B. Falini | A. Banham | P. Pelicci | D. Mason | K. Pulford | E. Colombo | J. Cordell | D. Mason | B. Bigerna | G Roncador | D Y Mason | B Bigerna | G. Roncador | E Colombo | J L Cordell | K A Pulford | A Banham
[1] S. Pileri,et al. ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum. , 1998, The American journal of pathology.
[2] R. Berger,et al. Non-Hodgkin’s lymphomas and myeloid disorders: deletions associated with t(2;5) and t(3;5) detected by FISH , 1998, Leukemia.
[3] S. Pileri,et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. , 1998, Blood.
[4] K. Pulford,et al. Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation. , 1998, Cancer research.
[5] I. Valkov,et al. A new variant chromosomal translocation t(2;2)(p23;q23) in CD30+/Ki-1+ anaplastic large cell lymphoma. , 1998, Leukemia & lymphoma.
[6] C. Tribioli,et al. Gene rearrangements in the molecular pathogenesis of acute promyelocytic leukemia , 1997, Journal of cellular physiology.
[7] F. Behm,et al. Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. , 1997, Blood.
[8] S. Morris,et al. MNDA binds NPM/B23 and the NPM-MLF1 chimera generated by the t(3;5) associated with myelodysplastic syndrome and acute myeloid leukemia. , 1997, Experimental hematology.
[9] S. Pileri,et al. Antigen retrieval techniques in immunohistochemistry: comparison of different methods , 1997, The Journal of pathology.
[10] E. Campo,et al. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. , 1997, The American journal of pathology.
[11] I. Todorov,et al. Cell cycle-dependent translocations of a major nucleolar phosphoprotein, B23, and some characteristics of its variants. , 1997, European journal of cell biology.
[12] K. Pulford,et al. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis , 1997, Molecular and cellular biology.
[13] S. Pileri,et al. Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type. , 1997, The American journal of pathology.
[14] P. Brousset,et al. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation. , 1997, Blood.
[15] K. Pulford,et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. , 1997, Blood.
[16] S. Mori,et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. , 1995, Leukemia.
[17] W. Chan. The t(2;5) or NPM-ALK Translocation in Lymphomas: Diagnostic Considerations , 1996 .
[18] C. Peschle,et al. Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains. , 1996, The EMBO journal.
[19] Y. Y. Lu,et al. Decreased accumulation and dephosphorylation of the mitosis-specific form of nucleophosmin/B23 in staurosporine-induced chromosome decondensation. , 1996, The Biochemical journal.
[20] S. Pileri,et al. Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region. , 1996, The American journal of pathology.
[21] S. Corey,et al. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. , 1996, Blood.
[22] S. Raimondi,et al. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. , 1996, Oncogene.
[23] W. Dinjens,et al. EXPRESSION OF NUCLEOPHOSMIN/B23 IN NORMAL AND NEOPLASTIC COLORECTAL MUCOSA , 1996, The Journal of pathology.
[24] C. Scrideli,et al. Translocation (1;5)(q32;q35) in CD30+ anaplastic large cell non-Hodgkin lymphona of childhood. A case report. , 1996, Cancer genetics and cytogenetics.
[25] A. Bernheim,et al. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. , 1996, Blood.
[26] P. Pandolfi. PML, PLZF and NPM genes in the molecular pathogenesis of acute promyelocytic leukemia. , 1996, Haematologica.
[27] A. Feller,et al. Presence of the t(2;5) in Hodgkin's disease. , 1995, Blood.
[28] W. Chan,et al. Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions. , 1995, Blood.
[29] C. Mecucci,et al. A new t(2;5) translocation in a null cell type CD30 positive anaplastic large cell lymphoma case. , 1995, Leukemia.
[30] J. Rüschoff,et al. In vitro and ex vivo expression of nucleolar proteins B23 and p120 in benign and malignant epithelial lesions of the prostate. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[31] M. Wu,et al. Translocation of nucleophosmin from nucleoli to nucleoplasm requires ATP. , 1995, The Biochemical journal.
[32] A. Feller,et al. Large-cell anaplastic lymphoma-specific translocation (t[2;5] [p23;q35]) in Hodgkin's disease: indication of a common pathogenesis? , 1995, The Lancet.
[33] D N Shapiro,et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. , 1994, Science.
[34] S. Poppema. Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease. , 1995, Lancet.
[35] H. Satoh,et al. Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. , 1994, Blood.
[36] H. Satoh,et al. Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. , 1994, Oncogene.
[37] S. Pileri,et al. Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas. , 1994, Cancer research.
[38] P. Chan. Characterization and cellular localization of nucleophosmin/B23 in HeLa cells treated with selected cytotoxic agents (studies of B23-translocation mechanism). , 1992, Experimental cell research.
[39] P. Chan,et al. The major phosphorylation site of nucleophosmin (B23) is phosphorylated by a nuclear kinase II. , 1990, The Biochemical journal.
[40] B. Yung,et al. Immunolocalization of phosphoprotein B23 in proliferating and non‐proliferating hela cells , 1990, International journal of cancer.
[41] G. Basso,et al. A NOVEL VARIANT TRANSLOCATION t(2;13) (p23;q34) IN Ki‐1 LARGE CELL ANAPLASTIC LYMPHOMA , 1990, British journal of haematology.
[42] J. Labbé,et al. Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase , 1990, Cell.
[43] R. Warnke,et al. CD30‐positive large cell lymphomas (‘Ki‐1 lymphoma’) are associated with a chromosomal translocation involving 5q35 , 1990, British journal of haematology.
[44] S. Kaufmann,et al. Simultaneous immunoelectron microscopic visualization of protein B23 and C23 distribution in the HeLa cell nucleolus. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[45] C. Lehner,et al. Major nucleolar proteins shuttle between nucleus and cytoplasm , 1989, Cell.
[46] F. Berger,et al. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (‘Ki‐1 lymphoma') , 1989, British journal of haematology.
[47] M. Ashburner. A Laboratory manual , 1989 .
[48] N. Feuerstein,et al. Identification of numatrin, the nuclear matrix protein associated with induction of mitogenesis, as the nucleolar protein B23. Implication for the role of the nucleolus in early transduction of mitogenic signals. , 1988, The Journal of biological chemistry.
[49] M. Aldrich,et al. Assessment of tumor cell sensitivity to mitomycin C by "B23 translocation" assay. , 1988, Cancer letters.
[50] K. Lennert,et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. , 1985, Blood.
[51] D. Mason,et al. IMMUNOCYTOCHEMICAL DETECTION OF T AND B CELL POPULATIONS IN ROUTINE BLOOD SMEARS , 1984, The Lancet.
[52] H Stein,et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). , 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[53] R. Ochs,et al. Localization of nucleolar phosphoproteins B23 and C23 during mitosis. , 1983, Experimental cell research.
[54] H. Busch,et al. Nucleolar localization of protein B23 (37/5.1) by immunocytochemical techniques. , 1981, Life sciences.
[55] J. Loudon. Letter: Training in family planning. , 1975, Lancet.
[56] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.